Regulation of intestinal homeostasis and immunity with probiotic lactobacilli

Trends in Immunology

Volumn 34, Issue 5, 2013, Pages 208-215

  van Baarlen, Peter ^a   Wells, Jerry M ^a   Kleerebezem, Michiel ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Gastrointestinal health; Host microbe interactions; Immunomodulation; Personalization; Probiotics; Resilience

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD209 ANTIGEN; LECTIN RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PROBIOTIC AGENT; TOLL LIKE RECEPTOR;

ANTIGEN EXPRESSION; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; CYTOKINE RESPONSE; DENDRITIC CELL; GENETIC DIFFERENCE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; INTRACELLULAR SIGNALING; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MICROFLORA; NONHUMAN; PEYER PATCH; REVIEW;

ANIMALS; GENE-ENVIRONMENT INTERACTION; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASES; INTESTINES; LACTOBACILLUS; MICROBIOTA; PROBIOTICS;

EID: 84877136407     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.01.005     Document Type: Review

References (83)

1. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
2. Maynard C.L., et al. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012, 489:231-241.
3. Rautava S., et al. Microbial contact during pregnancy, intestinal colonization and human disease. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:565-576.
4. Sartor R.B. Gut microbiota: diet promotes dysbiosis and colitis in susceptible hosts. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:561-562.
5. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
6. Sartor R.B. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16413-16414.
7. Gareau M.G., et al. Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:503-514.
8. DuPont A.W., DuPont H.L. The intestinal microbiota and chronic disorders of the gut. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:523-531.
9. Floch M.H., et al. Recommendations for probiotic use-2011 update. J. Clin. Gastroenterol. 2011, 45(Suppl.):S168-S171.
10. Sazawal S., et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 2006, 6:374-382.
11. Szajewska H., et al. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J. Pediatr. 2006, 149:367-372.
12. Kalliomaki M., et al. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J. Nutr. 2010, 140:713S-721S.
13. Bron P.A., et al. Lactobacillus plantarum possesses the capability for wall teichoic acid backbone alditol switching. Microb. Cell Fact. 2012, 11:123.
14. Remus D.M., et al. Impact of 4 Lactobacillus plantarum capsular polysaccharide clusters on surface glycan composition and host cell signaling. Microb. Cell Fact. 2012, 11:149.
15. Lebeer S., et al. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 2010, 8:171-184.
16. Wells J.M., et al. Epithelial crosstalk at the microbiota-mucosal interface. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl. 1):4607-4614.
17. Bron P.A., et al. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat. Rev. Microbiol. 2012, 10:66-78.
18. Grangette C., et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10321-10326.
19. Perea Velez M., et al. Functional analysis of d-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 2007, 73:3595-3604.
20. Khan M.W., et al. Modulating intestinal immune responses by lipoteichoic acid-deficient Lactobacillus acidophilus. Immunotherapy 2012, 4:151-161.
21. Khazaie K., et al. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl. Acad Sci. U.S.A. 2012, 109:10462-10467.
22. Macho Fernandez E., et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 2011, 60:1050-1059.
23. Kleerebezem M., et al. The extracellular biology of the lactobacilli. FEMS Microbiol. Rev. 2010, 34:199-230.
24. Kankainen M., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17193-17198.
25. Lebeer S., et al. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl. Environ. Microbiol. 2012, 78:185-193.
26. Yan F., Polk D.B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 2002, 277:50959-50965.
27. Yan F., et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007, 132:562-575.
28. Yan F., et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 2011, 121:2242-2253.
29. Claes I.J., et al. Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG. PLoS ONE 2012, 7:e31588.
30. von Schillde M.A., et al. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 2012, 11:387-396.
31. Meijerink M., et al. Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS ONE 2010, 5:e10632.
32. Meijerink M., et al. Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model. FEMS Immunol. Med. Microbiol. 2012, 65:488-496.
33. Wells J.M. Immunomodulatory mechanisms of lactobacilli. Microb. Cell Fact. 2011, 10(Suppl. 1):S17.
34. Lee I.C., et al. The quest for probiotic effector molecules-unraveling strain specificity at the molecular level. Pharmacol. Res. 2013, 69:61-74.
35. van Hemert S., et al. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol. 2010, 10:293.
36. Clark E.E., et al. Absence of serotype-specific surface antigen and altered teichoic acid glycosylation among epidemic-associated strains of Listeria monocytogenes. J. Clin. Microbiol. 2000, 38:3856-3859.
37. Xia G., et al. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J. Biol. Chem. 2010, 285:13405-13415.
38. Fredriksen L., et al. The major autolysin Acm2 from Lactobacillus plantarum undergoes cytoplasmic O-glycosylation. J. Bacteriol. 2012, 194:325-333.
39. Lebeer S., et al. The major secreted protein Msp1/p75 is O-glycosylated in Lactobacillus rhamnosus GG. Microb. Cell Fact. 2012, 11:15.
40. Konstantinov S.R., et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19474-19479.
41. van Baarlen P., et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2371-2376.
42. Sansonetti P.J., Medzhitov R. Learning tolerance while fighting ignorance. Cell 2009, 138:416-420.
43. Shanahan F. Probiotics in perspective. Gastroenterology 2010, 139:1808-1812.
44. Hasegawa M., et al. Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J. Biol. Chem. 2006, 281:29054-29063.
45. Petnicki-Ocwieja T., et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15813-15818.
46. Geijtenbeek T.B., Gringhuis S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009, 9:465-479.
47. Rabinovich G.A. A sweet path toward tolerance in the gut. Nat. Med. 2010, 16:1076-1077.
48. Smits H.H., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005, 115:1260-1267.
49. Ghishan F.K., Kiela P.R. From probiotics to therapeutics: another step forward?. J. Clin. Invest. 2011, 121:2149-2152.
50. Lebeer S., et al. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008, 72:728-764.
51. Kwon H.K., et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2159-2164.
52. Jeon S.G., et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog. 2012, 8:e1002714.
53. Geuking M.B., et al. The continuum of intestinal CD4+ T cell adaptations in host-microbial mutualism. Gut Microbes 2011, 2:353-357.
54. Lavasani S., et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 2010, 5:e9009.
55. Sheil B., et al. Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin. Exp. Immunol. 2006, 144:273-280.
56. Kaji R., et al. Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J. Immunol. 2010, 184:3505-3513.
57. Karczewski J., et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G851-G859.
58. van Baarlen P., et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl. 1):4562-4569.
59. Mariat D., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009, 9:123.
60. Vael C., Desager K. The importance of the development of the intestinal microbiota in infancy. Curr. Opin. Pediatr. 2009, 21:794-800.
61. Atarashi K., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
62. Hooper L.V., et al. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
63. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
64. Olszak T., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.
65. Jostins L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
66. Renz H., et al. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat. Rev. Immunol. 2012, 12:9-23.
67. Klaenhammer T.R., et al. The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 2012, 12:728-734.
68. Minot S., et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011, 21:1616-1625.
69. Zoetendal E.G., et al. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57:1605-1615.
70. Zoetendal E.G., et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 2012, 6:1415-1426.
71. Gaboriau-Routhiau V., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
72. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134:577-594.
73. Mazmanian S.K., et al. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
74. Manichanh C., et al. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:599-608.
75. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9:313-323.
76. Reid G., et al. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat. Rev. Microbiol. 2011, 9:27-38.
77. Sokol H., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16731-16736.
78. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12204-12209.
79. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8:411-420.
80. Cario E., et al. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
81. Rehman A., et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011, 60:1354-1362.
82. Strober W., Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol. 2011, 4:484-495.
83. Gijzen K., et al. Relevance of DC-SIGN in DC-induced T cell proliferation. J. Leukoc. Biol. 2007, 81:729-740.